AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Bio Green Med Solution, Inc. Director's Dealing 2025

Jan 8, 2025

35092_dirs_2025-01-08_5ec65533-f1c4-49b0-9d27-2ca779eae877.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2025-01-05

Reporting Person: Ben-Tzvi Avraham (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct

Footnotes

F1: No securities are beneficially owned.